11.12.2013 15:50 Uhr, Quelle: Wallstreet online

Regen BioPharma Announces HemaXellerate I(TM) Efficacy Data in Animal Model of Aplastic Anemia

SAN DIEGO, CA--(Marketwired - Dec 11, 2013) - Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) announced today results of ongoing experiments in collaboration with Dr. Wei-Ping Min of the University of Western Ontario using HemaXellerate I™ to …

Weiterlesen bei Wallstreet online

Digg del.icio.us Facebook email MySpace Technorati Twitter

JustMac.info © Thomas Lohner - Impressum - Datenschutz